Key safety findings include: No established LD50: Researchers haven't been able to determine a lethal dose in animal models, even at doses many times higher than therapeutic ranges No observed organ toxicity: Studies examining the effects of BPC-157 on liver, kidney, heart, and other organs haven't shown toxic effects No hormonal disruption: Unlike many compounds used for recovery and healing (such as growth hormone secretagogues or anabolic agents), BPC-157 doesn't appear to alter endocrine function No tumor promotion: Studies conducted to date haven't shown that BPC-157 promotes tumor growth or increases cancer risk, though this is an area that warrants continued monitoring Stable across administration routes: Both oral and injectable BPC-157 have shown comparable safety profiles Reported Side Effects Based on clinical observations and user reports, the side effects of BPC-157 are generally mild and self-limiting: Common Side Effects (Mild, Transient) Injection site reactions: Mild redness, minor swelling, or slight discomfort at the injection site
doi:10.2147/CCID.S128339 Handog EB, Datuin MS, Singzon IA
EGRIFTA WR stimulates GH production
GLP-1 options include Wegovy pill or pen, Mounjaro, Ozempic, Zepbound pen or vial, and Foundayo pills
[5] Self-pay pricing starts at $149/month for Foundayo
Its called body protective compound
